CHRONIC NEUROPATHIC PAIN IN POST COVID PATIENTS RELATION WITH DISEASE SEVERITY

Post-COVID syndrome, also known as post-acute sequelae of SARS-CoV-2 infection, has been associated with various long-term effects, one of which is neuropathic pain. This condition is characterized by chronic pain arising from nerve injury and has been observed in many patients recovering from COVID-19, potentially correlating with the severity of the initial infection. Objective: The study aimed to compare the prevalence and types of neuropathic pain in post-COVID patients and investigate the correlation between chronic neuropathic pain and the severity of the initial COVID-19 infection. Methods: This prospective observational study was conducted at the Department of Medicine, SKBZ/CMH Hospital Muzaffarabad, AJK, from February to August 2024. One hundred fifty post-COVID patients were enrolled, categorized into mild/moderate and severe groups (50 patients each). Neuropathic pain was assessed using the Neuropathic Pain Scale (NPS) at three and six months post-infection. Statistical analysis was performed using Analysis of Variance (ANOVA) to compare mean responses, with p-values < 0.05 considered statistically significant. Results: Out of 150 patients, 53.3% (80 patients) reported experiencing chronic neuropathic pain. Neuropathic pain was more prevalent in patients who had severe COVID-19 symptoms, with 65% of severe cases reporting pain, compared to 40% of mild/moderate cases. The mean NPS score was significantly higher in severe cases (6.8 ± 1.2) compared to mild/moderate cases (4.3 ± 1.0), with a p-value of < 0.01, indicating a strong association between the severity of the initial infection and the subsequent development of neuropathic pain. Conclusion: There is a higher incidence and severity of chronic neuropathic pain in post-COVID patients, particularly those who experienced severe disease manifestations. Early identification and targeted pain management strategies are essential for mitigating the long-term impact of neuropathic pain in these patients.

Authors

Institutions

Publication Details

Journal
Biological and Clinical Sciences Research Journal
Published
2024-09-27
DOI
https://doi.org/10.54112/bcsrj.v2024i1.1134
Primary Topic
Pain Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CHRONIC NEUROPATHIC PAIN IN POST COVID PATIENTS RELATION WITH DISEASE SEVERITY

M Masud Iqbal, Maria Nazir, Abdullahi Ishaq, Lubna Khalid et al.
Biological and Clinical Sciences Research Journal
Pain Mechanisms and Treatments
article

CHRONIC NEUROPATHIC PAIN IN POST COVID PATIENTS RELATION WITH DISEASE SEVERITY

M Masud Iqbal, Maria Nazir, Abdullahi Ishaq, Lubna Khalid, ZM MUGHAL, NUS AWAN
article en

Abstract

Post-COVID syndrome, also known as post-acute sequelae of SARS-CoV-2 infection, has been associated with various long-term effects, one of which is neuropathic pain. This condition is characterized by chronic pain arising from nerve injury and has been observed in many patients recovering from COVID-19, potentially correlating with the severity of the initial infection. Objective: The study aimed to compare the prevalence and types of neuropathic pain in post-COVID patients and investigate the correlation between chronic neuropathic pain and the severity of the initial COVID-19 infection. Methods: This prospective observational study was conducted at the Department of Medicine, SKBZ/CMH Hospital Muzaffarabad, AJK, from February to August 2024. One hundred fifty post-COVID patients were enrolled, categorized into mild/moderate and severe groups (50 patients each). Neuropathic pain was assessed using the Neuropathic Pain Scale (NPS) at three and six months post-infection. Statistical analysis was performed using Analysis of Variance (ANOVA) to compare mean responses, with p-values < 0.05 considered statistically significant. Results: Out of 150 patients, 53.3% (80 patients) reported experiencing chronic neuropathic pain. Neuropathic pain was more prevalent in patients who had severe COVID-19 symptoms, with 65% of severe cases reporting pain, compared to 40% of mild/moderate cases. The mean NPS score was significantly higher in severe cases (6.8 ± 1.2) compared to mild/moderate cases (4.3 ± 1.0), with a p-value of < 0.01, indicating a strong association between the severity of the initial infection and the subsequent development of neuropathic pain. Conclusion: There is a higher incidence and severity of chronic neuropathic pain in post-COVID patients, particularly those who experienced severe disease manifestations. Early identification and targeted pain management strategies are essential for mitigating the long-term impact of neuropathic pain in these patients.

Biological and Clinical Sciences Research JournalVol. 2024(1)
University of Azad Jammu and Kashmir (PK), Polyclinic Medical Center (US), Mater Misericordiae University Hospital (IE), Polyclinic General Hospital (GR)
Openalex Percentile: Top 77%
Pain Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.